PLoS Biology

PLoS Biology is a peer-reviewed scientific journal covering all aspects of biology. Publication began on October 13, 2003. It was the first journal of the Public Library of Science. All content in PLoS Biology is published under the Creative Commons "by-attribution" license. To fund the journal, the publication s business model requires that, in most cases, authors will pay publication costs. In addition to research articles, PLoS Biology publishes online e-letters in which readers provide comments on articles. According to the Journal Citation Reports, the journal has a 2009 impact factor of 12.916, ranking it first in the category Biology . Mike Taylor of Discover Magazine said in 2012 that while PLoS Biology has a high impact factor, "PLoS has de-emphasized this traditional, problematic measure, so you won’t find this fact blazoned across their website." The current editor-in-chief is Jonathan Eisen (University of California, Davis). Due to their free licensing, files from PLoS Biology can be reused in places other than the original article, e.g. to illustrate Wikipedia articles.

Publisher
Public Library of Science
History
2003–present
Impact factor
12.916 (2009)

Some content from Wikipedia, licensed under CC BY-SA

Medical research

A closer look at the blood-brain barrier

(Medical Xpress)—Thousands of people today have various kinds of stimulators placed deep in their brains in the hope of curing their ills. Many others require systems of tubes, catheters, and shunts penetrating deep into ...

Medical research

A new pathway for an anti-aging drug

In 1972, Easter Island, called Rapa Nui, famous for its moai statues, offered a new wonder: the discovery of the drug rapamycin.

Genetics

What can be done to prevent another CRISPR crisis?

The public announcement last fall from China regarding gene editing on human embryos, conducted without the benefit of scientific review or ethical debate, was met with worldwide disdain. It also has raised global concerns ...

Diseases, Conditions, Syndromes

Designer drugs to inhibit hepatitis A virus

Structure-based drug design revealed that a compound previously investigated for the treatment of head-and-neck cancer could function as a lead compound for the development of drugs to treat hepatitis A virus infection, according ...

Genetics

Mice reveal 38 new genes involved in hearing loss

Multiple new genes involved in hearing loss have been revealed in a large study of mouse mutants by researchers from the Wellcome Sanger Institute and King's College London, and colleagues. The new genes identified reveal ...

page 1 from 19